UCL is involved in the Rosalind Franklin Institute (RFI) – a major new £100 million investment by the government into the development of an innovative multi-disciplinary science and technology research centre.
Publication date: 23 February 2017
Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells, finds new UCL-led research funded by the Engineering and Physical Sciences Research Council.
Publication date: 3 February 2017
A new test for bladder cancer could enable GPs to test a urine sample and spare patients the discomfort of a cystoscopy in hospital, according to UCL research published today in Clinical Epigenetics.
Publication date: 31 January 2017
A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.
Publication date: 20 December 2016
Many pain-sensing nerves in the body are thought to respond to all types of ‘painful events’, but new UCL research in mice reveals that in fact most are specialised to respond to specific types such as heat, cold or mechanical pain.
Publication date: 14 November 2016
The risk of developing a psychotic disorder such as schizophrenia is highest for young people, men, ethnic minorities and people living in urban areas and poorer neighbourhoods, finds a new study by UCL and the University of Cambridge.
Publication date: 24 October 2016
Human Papillomavirus (HPV) drives a greater number of head and neck cancers than previously thought, finds new research from UCL and the University of Southampton.
Publication date: 6 October 2016
A new spin-out company Achilles Therapeutics has been launched to develop immunotherapies for cancer, based on the work of scientists from UCL and its associated hospitals.
Publication date: 5 October 2016
UCL’s three biomedical research centres (BRCs) have won more
than £167 million in funding from the National Institute for Health Research
(NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more
funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively.
Publication date: 14 September 2016
The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs. Next to St Pancras station and the British Library, the Crick will be the biggest biomedical research institute under one roof in Europe.
Publication date: 1 September 2016
An international study involving UCL has made advances in understanding the ways in which genetic risk factors alter gene function in schizophrenia.
Publication date: 30 August 2016
Researchers at UCL and Queen’s University Belfast have discovered that a drug originally developed to treat cardiovascular disease has the potential to reduce diabetes related blindness.
Publication date: 14 June 2016
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London.
Publication date: 10 June 2016
Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust.
Publication date: 22 April 2016
Universities and Science Minister Jo Johnson has sought to reassure researchers that the proposed restrictions preventing the use of government grants to ‘lobby’ government will not apply to funding from the Research Councils, HEFCE or the National Academies.
Publication date: 21 April 2016
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice led by UCL, Memorial Sloan Kettering (MSK) Cancer Center in New York and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona.
Publication date: 31 March 2016
A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center.
Publication date: 24 March 2016
The reason why the body’s immune cells cause so much damage and can’t regulate themselves in patients with lupus has been revealed in a UCL study published in the journal Immunity, a finding which could lead to more effective ways of treating lupus.
Publication date: 9 March 2016
Scientists at UCL have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system, even when the disease is at its most advanced stages.
Publication date: 4 March 2016
A group of drugs being developed to treat mood disorders could also relieve chronic pain, finds new UCL research funded by the Medical Research Council.
Publication date: 11 February 2016
HIV drug resistance to tenofovir, an antiretroviral drug vital to most
modern HIV treatment and prevention strategies, is surprisingly and worryingly common
according to a large study led by UCL and funded by the Wellcome Trust.
Publication date: 29 January 2016
Two papers from UCL show that having early chemotherapy improves survival for men with prostate cancer. The papers, published in the Lancet and Lancet Oncology, report the results from the STAMPEDE clinical trial and a meta-analysis.
Publication date: 22 December 2015
New results from the world’s biggest ovarian cancer screening trial led by UCL suggest that screening based on an annual blood test may help reduce the number of women dying from the disease by around 20%.
Publication date: 17 December 2015
A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration.
Publication date: 16 July 2015
UCL has successfully coordinated a £16 million bid to work with the Medical Research Council (MRC), GSK and four other universities to improve scientists’ understanding of inflammatory and fibrotic diseases that present a serious burden to patients.
Publication date: 15 July 2015